Gene therapy is making a comeback, with a flood deals, stock market debuts and increased investment by big pharmaceutical companies. 1972 - Researchers first suggest gene therapy as a treatment ...

The timeline and steps provide a guide for development of other customized gene therapies. KJ's treatment was presented this week at the American Society of Gene & Cell Therapy Annual Meeting in ...

PALO ALTO, Calif., June 02, 2025--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the results of the Phase III SERENA-6 trial - sponsored by ...

A new publication shines a spotlight on HER3, a long-overlooked member of the ErbB receptor family, revealing its critical role in cancer progression and resistance to therapy.

The combination reduced the risk of cancer progression or death by more than 40%, compared with imlunestrant alone. In the international, phase 3 clinical trial, imlunestrant improved progression-free ...

First pivotal trial to use a circulating tumor DNA (ctDNA)-guided approach to detect and treat emerging resistance in 1st-line therapy ahead of disease progression in breast cancer Trial showed ...